BioXcel Therapeutics, Inc. (BTAI) Discussion of Managing Acute Agitation in Schizophrenia and Bipolar Disorders at Home Transcript
Summarize this article with:
SA Transcripts157.31K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call BioXcel Therapeutics, Inc. (BTAI) Discussion of Managing Acute Agitation in Schizophrenia and Bipolar Disorders at Home December 8, 2025 10:02 AM EST Company Participants Vimal Mehta - Founder, CEO, President, & Director Conference Call Participants Anjalee KhemlaniLeslie CitromeLeon RavinMarc A.
Milano Presentation Vimal MehtaFounder, CEO, President, & Director Good morning, everyone, and thank you for joining us today. I would like to start by welcoming our distinguished participants. We are grateful to each of you for bringing your deep experience in the agitation space to help us shape this important discussion. Your insights are essential as we continue working to improve care for the millions of patients and families managing acute agitation associated with schizophrenia and bipolar disorders in the home setting. I would also like to thank our moderator, Anjalee Khemlani, an award-winning journalist known for our thoughtful and in-depth reporting on health care. We are delighted to have her guide today's conversation and introduce the clinical experts who will be sharing their perspective. An episodes of acute agitation remain a significant challenge, especially for those navigating them outside clinical environment, the need for practical patient-centered innovation has never been clearer. Today's roundtable reflects our commitment to advancing solutions that can help reduce the burden on patients, caregivers and the health care system as a whole. Our mission at BioXcel Therapeutics is to transform patient care and conversations like the one we are about to have play a meaningful role in shaping the future of how agitation is recognized and managed in real-world setting. With that, I would like to turn it over to Anjalee to begin the discussion.
Anjalee Khemlani Thank you so much for that introduction, Vimal, and a pleasure to be here with you all today. As noted, I am a health care journalist and have been Recommended For You